Concepedia
Statistics
Publications
6
Citations
496
H-Index
Active since
2008
Affiliations
The Netherlands Cancer Institute(Current)
Oncode Institute
Skolkovo Institute of Science and Technology
Jan-Paul Lambooij is an author at The Netherlands Cancer Institute specializing in genetics, medicine, and oncogenic signaling pathways.
Publications per year
2008–2025
SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
Giustina Ferone, Ji‐Ying Song, Rajith Bhaskaran et al. · Cancer Cell · 2016 · 255 citations · Full text
Medicine, Genetics, Oncology +17
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
Ekaterina A. Semenova, Min‐Chul Kwon, Kim Monkhorst et al. · Cell Reports · 2016 · 159 citations · Full text
Medicine, Genetics, Oncology +16
In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation
Panthea Taghavi, Els Verhoeven, Jacqueline J.L. Jacobs et al. · Oncogene · 2008 · 39 citations
Medicine, Genetics, Molecular Biology +16
A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis
Paul Krimpenfort, M. Snoek, Jan-Paul Lambooij et al. · Nature Communications · 2019 · 17 citations · Full text
Gene expression regulation by the Chromodomain helicase DNA-binding protein 9 (CHD9) chromatin remodeler is dispensable for murine development
Andrej Alendar, Jan-Paul Lambooij, Rajith Bhaskaran et al. · PLoS ONE · 2020 · 13 citations · Full text
Life Sciences, Developmental Biology, Genetics +15
1–5 of 6